(18) identified a CRGs signature (FDX1, DLAT and CDKN2A) in clear cell renal cell carcinoma (ccRCC) and found it could serve as a potential prognostic predictor for ccRCC. The gene discussed is CDKN2A; the disease is nonpapillary renal cell carcinoma.